A6V (p.Ala6Val) variant of GCK (Hexokinase-4)

A6V (p.Ala6Val) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar and UniProt describe it as uncertain significance in the context of Monogenic diabetes. The available variant effect predictions contribute to a CATVariant prioritization score of 0.49 / 1. The record also includes population frequency data and structural context.

A6V (p.Ala6Val) variant details